THE HEMODYNAMIC-EFFECTS OF CORRECTION OF ANEMIA IN HEMODIALYSIS-PATIENTS USING RECOMBINANT-HUMAN-ERYTHROPOIETIN

被引:0
|
作者
ABDULHADI, MH
FOUADTARAZI, FM
THOMAS, T
BRAVO, EL
PAGANINI, EP
机构
[1] CLEVELAND CLIN EDUC FDN, DEPT HYPERTENS, CLEVELAND, OH 44106 USA
[2] CLEVELAND CLIN EDUC FDN, DEPT HEART & HYPERTENS, CLEVELAND, OH 44106 USA
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:102 / 108
页数:7
相关论文
共 50 条
  • [31] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY ON BLOOD-PRESSURE IN HEMODIALYSIS-PATIENTS
    BURGESS, ED
    AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (01) : 23 - 26
  • [32] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PLATELET-FUNCTION IN ANEMIC HEMODIALYSIS-PATIENTS
    MARTIN, MJ
    CERVERO, A
    SANCHEZ, M
    MOLL, R
    SANCHIS, J
    VILLARO, J
    PEREZ, A
    KIDNEY INTERNATIONAL, 1990, 37 (06) : 1585 - 1585
  • [33] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT ON HEMODYNAMIC PARAMETERS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS AND HEMODIALYSIS-PATIENTS
    FERNANDEZ, A
    VEGA, N
    JIMENEZ, F
    MACIA, M
    LARAUDIOGOITIA, E
    HORTAL, L
    PERDOMO, M
    PLAZA, C
    RODRIGUEZ, JC
    PALOP, L
    AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (04) : 207 - 211
  • [34] ONCE WEEKLY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN HEMODIALYSIS-PATIENTS
    LAGO, M
    PEREZGARCIA, R
    DEVINUESA, MSG
    VILLAVERDE, M
    ANAYA, F
    VALDERRABANO, F
    KIDNEY INTERNATIONAL, 1994, 46 (02) : 579 - 579
  • [35] USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RH-EPO) IN THE TREATMENT OF ANEMIA IN HEMODIALYSIS-PATIENTS - A MULTICENTER ITALIAN EXPERIENCE
    BUCCIANTI, G
    COLOMBI, L
    BATTISTEL, V
    HAEMATOLOGICA, 1993, 78 (02) : 111 - 117
  • [36] CORRECTION OF ANEMIA WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN 15 LONG-TERM HEMODIALYSIS-PATIENTS - 12-20 MONTHS FOLLOW-UP
    JACQUOT, C
    BERTHELOT, JM
    CHIAPPINIJUDITH, D
    FERRAGUHAGUET, M
    LEFEBVRE, A
    MASSELOT, JP
    MOYNOT, A
    FRYDMAN, MO
    PETERLONGO, F
    NEPHROLOGIE, 1990, 11 (01): : 11 - 16
  • [37] RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ANEMIC PATIENTS ON HEMODIALYSIS
    BOMMER, J
    MULLERBUHL, E
    RITZ, E
    EIFERT, J
    LANCET, 1987, 1 (8529): : 392 - 392
  • [38] CHANGES IN PLASMA ENDOTHELIN CONCENTRATION AND HEMODYNAMIC PARAMETERS DURING RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) ADMINISTRATION IN MAINTENANCE HEMODIALYSIS-PATIENTS
    KANG, DH
    CHOI, KB
    YOON, KI
    HAN, DS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 539 - 539
  • [39] COMPARATIVE CROSSOVER STUDY OF INTRAVENOUSLY AND SUBCUTANEOUSLY ADMINISTERED RECOMBINANT-HUMAN-ERYTHROPOIETIN IN HEMODIALYSIS-PATIENTS
    STEFFENSEN, G
    AUNSHOLT, NA
    AHLBOM, G
    BLOOD PURIFICATION, 1992, 10 (5-6) : 241 - 247
  • [40] LACK OF INFLUENCE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PARATHYROID FUNCTION IN HEMODIALYSIS-PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
    LAI, YH
    TSAI, JC
    CHEN, HC
    GUH, JY
    HWANG, SJ
    TSAI, JH
    NEPHRON, 1995, 70 (02) : 223 - 228